Literature DB >> 32233432

Exploring Conformational Dynamics of the Extracellular Venus flytrap Domain of the GABAB Receptor: A Path-Metadynamics Study.

Linn S M Evenseth1, Riccardo Ocello2,3, Mari Gabrielsen1, Matteo Masetti2, Maurizio Recanatini2, Ingebrigt Sylte1, Andrea Cavalli2,3.   

Abstract

γ-Aminobutyric acid (GABA) is the main inhibitory neurotransmitter in the central nervous system (CNS). Dysfunctional GABAergic neurotransmission is associated with numerous neurological and neuropsychiatric disorders. The GABAB receptor (GABAB-R) is a heterodimeric class C G protein-coupled receptor (GPCR) comprised of GABAB1a/b and GABAB2 subunits. The orthosteric binding site for GABA is located in the extracellular Venus flytrap (VFT) domain of the GABAB1a/b. Knowledge about molecular mechanisms and druggable receptor conformations associated with activation is highly important to understand the receptor function and for rational drug design. Currently, the conformational changes of the receptor upon activation are not well described. On the basis of other class C members, the VFT is proposed to fluctuate between an open/inactive and closed/active state and one of these conformations is stabilized upon ligand binding. In the present study, we investigated the dynamics of the GABAB1b-R VFT in the apo form by combining unbiased molecular dynamics with path-metadynamics. Our simulations confirmed the open/inactive and closed/active state as the main conformations adopted by the receptor. Sizeable energy barriers were found between stable minima, suggesting a relatively slow interconversion. Previously undisclosed metastable states were also identified, which might hold potential for future drug discovery efforts.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32233432      PMCID: PMC7997371          DOI: 10.1021/acs.jcim.0c00163

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  35 in total

1.  Positive allosteric modulators for gamma-aminobutyric acid(B) receptors open new routes for the development of drugs targeting family 3 G-protein-coupled receptors.

Authors:  J P Pin; M L Parmentier; L Prézeau
Journal:  Mol Pharmacol       Date:  2001-11       Impact factor: 4.436

2.  No ligand binding in the GB2 subunit of the GABA(B) receptor is required for activation and allosteric interaction between the subunits.

Authors:  Julie Kniazeff; Thierry Galvez; Gilles Labesse; Jean-Philippe Pin
Journal:  J Neurosci       Date:  2002-09-01       Impact factor: 6.167

Review 3.  Structure and ligand recognition of class C GPCRs.

Authors:  Lei Chun; Wen-hua Zhang; Jian-feng Liu
Journal:  Acta Pharmacol Sin       Date:  2012-01-30       Impact factor: 6.150

4.  Role of Molecular Dynamics and Related Methods in Drug Discovery.

Authors:  Marco De Vivo; Matteo Masetti; Giovanni Bottegoni; Andrea Cavalli
Journal:  J Med Chem       Date:  2016-02-08       Impact factor: 7.446

5.  The role of the peripheral anionic site and cation-pi interactions in the ligand penetration of the human AChE gorge.

Authors:  Davide Branduardi; Francesco Luigi Gervasio; Andrea Cavalli; Maurizio Recanatini; Michele Parrinello
Journal:  J Am Chem Soc       Date:  2005-06-29       Impact factor: 15.419

6.  From A to B in free energy space.

Authors:  Davide Branduardi; Francesco Luigi Gervasio; Michele Parrinello
Journal:  J Chem Phys       Date:  2007-02-07       Impact factor: 3.488

7.  Direct detection of the interaction between recombinant soluble extracellular regions in the heterodimeric metabotropic gamma-aminobutyric acid receptor.

Authors:  Rei Nomura; Yoshikazu Suzuki; Akira Kakizuka; Hisato Jingami
Journal:  J Biol Chem       Date:  2007-12-28       Impact factor: 5.157

8.  Atomic-Level Characterization of the Chain-Flipping Mechanism in Fatty-Acids Biosynthesis.

Authors:  Francesco Colizzi; Matteo Masetti; Maurizio Recanatini; Andrea Cavalli
Journal:  J Phys Chem Lett       Date:  2016-07-15       Impact factor: 6.475

9.  Nicotine-induced molecular alterations are modulated by GABAB receptor activity.

Authors:  Andres P Varani; Valeria T Pedrón; Amira J Aon; Christian Höcht; Gabriela B Acosta; Bernhard Bettler; Graciela N Balerio
Journal:  Addict Biol       Date:  2017-04-17       Impact factor: 4.280

10.  Structural mechanism of ligand activation in human GABA(B) receptor.

Authors:  Yong Geng; Martin Bush; Lidia Mosyak; Feng Wang; Qing R Fan
Journal:  Nature       Date:  2013-12-04       Impact factor: 49.962

View more
  3 in total

Review 1.  The GABAB Receptor-Structure, Ligand Binding and Drug Development.

Authors:  Linn Samira Mari Evenseth; Mari Gabrielsen; Ingebrigt Sylte
Journal:  Molecules       Date:  2020-07-07       Impact factor: 4.411

Review 2.  Structural Characterization of Receptor-Receptor Interactions in the Allosteric Modulation of G Protein-Coupled Receptor (GPCR) Dimers.

Authors:  Raudah Lazim; Donghyuk Suh; Jai Woo Lee; Thi Ngoc Lan Vu; Sanghee Yoon; Sun Choi
Journal:  Int J Mol Sci       Date:  2021-03-22       Impact factor: 6.208

3.  Probing allosteric regulations with coevolution-driven molecular simulations.

Authors:  Francesco Colizzi; Modesto Orozco
Journal:  Sci Adv       Date:  2021-09-08       Impact factor: 14.136

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.